In particular, while cytotoxic CD4+ T cells have long been observed in tumor models and patients with cancer, recent work has highlighted their functional importance in recognizing MHC class II–restricted tumor antigens, and their regulation in vivo in patients (1, 4, 6–8, 30). This evidence concerns the gene CD4 and cancer.